pages:
-
A Novel Neurorehabilitation Approach for Cognitive Aging with HIV
-
A Novel Optogenetic Tool for Precise Mitochondrial Control
-
A Novel Peroxidase in Vascular Endothelium and the Development of Atherosclerosis
-
A Novel Proteolytic System of Pulmonary Inflammation
-
A Novel Proteolytic System of Pulmonary Inflammation
-
A Novel Regimen to Prevent Malaria and STIs in Pregnant Women with HIV
-
A Novel Role for IGF-1 Receptor in Growth Hormone Action
-
A Novel Role of AhR Mediated Intestinal Injury in Neonates
-
A Novel Source of Mucosal T Cells to Study Immunity in the Female Genital Tract
-
A Novel Stemness Program with Epigenetic Dysregulation in Acute Myeloid Leukemia
-
A Novel T-Cell Quiescence Mechanism in Anti-Ovarian Tumor Responses
-
A Novel Therapeutic Approach for Treating WNT-Driven Hepatocellular Carcinoma
-
A Novel Therapeutic Target for Treating Aggressive and Metastatic Hepatocellular Carcinoma
-
A Novel Transcriptional Vulnerability in Acute Myeloid Leukemia
-
A Novel Zebrafish Model of Thrombotic Thrombocytopenic Purpura
-
A Novel Zebrafish Model of Thrombotic Thrombocytopenic Purpura
-
A Novel, Transferable Sialylation-mediated Mechanism of Chemoradioresistance in GI Cancer
-
A Nurse-Led Structured Discharge Teaching Intervention for Parents of Newly Diagnosed Pediatric Oncology Patients
-
A Pathogenic Smoke Associated Neutrophilic Exosomal Pathway
-
A Patient Activation Intervention to Improve Bone Health in Older Adults
-
A Phase 1 / 2 Study of PF-02341066, an Oral Small Molecule Inhibitor of Anaplastic Lymphoma Kinase (ALK) and C-Met, in Children with Relapsed/Refractory Solid Tumors and Anaplastic Large Cell Lymphoma
-
A Phase 1 Study of M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma
-
A Phase 1, Open-Label, Dose-escalation trial of CD33xCD3 Bispecific Antibody in Pediatric patients with Relapsed of Refractory Acute Myeloid Leukemia - COG ADVL 2111
-
A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including CNS Tumors
-
A Phase 1b, Multi-center Study of IV Gallium Nitrate in Patients with Cystic Fibrosis who are Colonized with Nontuberculous Mycobacteria (The ABATE Study)
-
A Phase 2 Multicenter, Single-Arm, Open-Label Study to Evaluate the Activity, Safety and Pharmacokinetics of Lenalidomide (Revlimid®) in Pediatric Subjects from 1 To < 18 Years of Age with Relapsed or Refractory Acute Myeloid Leukemia
-
A Phase 2 Proof-of-concept Study to Evaluate the Efficacy and Safety of MEDI3902 in Mechanically Ventilated Patients for the Prevention of Nosocomial Pneumonia Caused by Pseudomonas aeruginosa
-
A Phase 2-B, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-NMDA Receptor Encephalitis and Assess Markers of Disease
-
A Phase 2/3 Open-label, Randomized, Sequential Dose Escalation Cohort Study of T2307 Versus Standard of Care in Treatment of Subjects with Candidemia due to Candida Auris and other Drug-resistant Candida Species: An Adaptive Design Study
-
A Phase 2a Randomized Controlled Trial of MIB-626 (ß Nicotinamide Mononucleotide, NMN) vs. Placebo in Adults with COVID-19 Infection and Early Acute Kidney Injury
pages:
